Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
DDD$2.99-0.04(-1.32%)Precision Resource Breaks Ground on Two New Production Additive Manufacturing Facilities and Expands Value-Added Services in Partnership with 3D Systems[4:30:00 PM ET]CI$295.00-3.28(-1.10%)The Cigna Group Declares Quarterly Dividend The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.56 per share of its common stock, payable on December 17,...[4:30:00 PM ET]TOWN$36.47-0.04(-0.11%)Townebank Reports Third Quarter 2026 Earnings[4:30:00 PM ET]ORLY$95.01+5.19(+5.78%)O’Reilly Automotive, Inc. Reports Third Quarter 2026 Results[4:30:00 PM ET]RNAZ$1.74+0.07(+4.19%)TransCode Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process Intended to Maximize Value of TTX-MC138 and its Oncology Portfolio TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), a clinical-stage biopharmaceutical company developing RNA-based...[4:30:00 PM ET]PFS$23.12-0.11(-0.47%)Provident Financial Services, Inc. Reports Third Quarter Earnings[4:30:00 PM ET]AWK$139.79-1.31(-0.93%)AMERICAN WATER REPORTS SOLID THIRD QUARTER 2026 RESULTS; NARROWS 2026 EPS GUIDANCE TO TOP HALF OF RANGE; AFFIRMS LONG-TERM TARGETS; INITIATES STANDALONE 2027 EPS GUIDANCE, REFLECTING GROWTH OF 8% American Water Works Company, Inc. (NYSE: AWK) today reported adjusted earnings for the quarter ended September 30, 2026, of $2.00 per share,...[4:30:00 PM ET]UTL$54.75-0.22(-0.40%)Unitil Declares Common Stock Dividend[4:30:00 PM ET]AMGN$462.00+14.05(+3.14%)AMGEN ANNOUNCES WEBCAST OF 2026 THIRD QUARTER FINANCIAL RESULTS Amgen (NASDAQ:AMGN) today announced that it will report its third quarter 2026 financial results on Tuesday, November 3, 2026, after the close of the ...[4:30:00 PM ET]TYFG$82.60-0.40(-0.48%)Tri-County Financial Group, Inc. Reports Third Quarter 2026 Financial Results Tri-County Financial Group, Inc. (the "Company") (OTCQX: TYFG) today announced financial results for the third quarter of 2026. Net income for the...[4:30:00 PM ET]STE$228.78+0.29(+0.13%)STERIS Announces Dividend of $0.69 per share[4:30:00 PM ET]OBT$38.10-0.35(-0.91%)Orange County Bancorp, Inc. Announces Record Third Quarter Earnings[4:30:00 PM ET]PFBX$23.410.00(0.00%)Peoples Financial Corporation Reports Third Quarter 2026 Results and Announces a 5.6% Increase in Its Regular Semi-Annual Dividend, From $0.18 to $0.19 per Common Share[4:30:00 PM ET]PSQL$5.80+0.15(+2.65%)Pasqal Announces Third Quarter 2026 Business Update and Participation in Upcoming Investor Conferences[4:30:00 PM ET]LENZ$3.06-0.09(-2.86%)LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession[4:30:00 PM ET]

SCNX · NASDAQ

Scienture Holdings, Inc.

$3.38 +0.24 (+7.64%)

Company overview

TRxADE HEALTH, Inc. operates as a health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics, and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ
Market cap
$5.6M
Employees
14
Headquarters
Tampa, FL
Website
trxadehealth.com
CEO
Shankar Hariharan
Listed
February 6, 2014
P/E
-1.38
Dividend yield
1.27%

Company financials

Revenue
$477,676
Gross profit
-$83,354
Operating income
-$15.4M
EBITDA
-$39.6M
Net income
-$41.9M
EPS
-$2.45
Total assets
$80.7B
Total debt
$10M
Gross margin
-17.45%
Net margin
-8,761.28%
Earnings yield
-72.34%

Revenue segmentation

By product (FY 2024)
By region (FY 2024)

Showing FY 2024

Price chart

-0.031.082.203.314.43
SCNX 1D NASDAQ O2.97H3.23L2.82C3.23+0.30 (+10.24%)Vol37.30K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
SCNXScienture Holdings, Inc. Stock news Scienture Holdings, Inc. (SCNX) Shareholder/Analyst Call Prepared Remarks Transcript Seeking Alpha
SCNXScienture Holdings, Inc. Press release SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027 GlobeNewswire
SCNXScienture Holdings, Inc. Press release SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth GlobeNewswire
SCNXScienture Holdings, Inc. Press release SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals GlobeNewsWire
SCNXScienture Holdings, Inc. Press release Scienture Holdings, Inc. Announces Reverse Stock Split GlobeNewswire
SCNXScienture Holdings, Inc. Press release SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner GlobeNewsWire
SCNXScienture Holdings, Inc. Press release SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026 GlobeNewswire
SCNXScienture Holdings, Inc. Press release SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance GlobeNewsWire
SCNXScienture Holdings, Inc. Press release SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray GlobeNewsWire
SCNXScienture Holdings, Inc. Press release SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers GlobeNewsWire
SCNXScienture Holdings, Inc. Press release SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers Globe News Wire
SCNXScienture Holdings, Inc. Press release SCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYC Accesswire
SCNXScienture Holdings, Inc. Press release SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041 GlobeNewsWire
SCNXScienture Holdings, Inc. Stock news SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion Globe News Wire
SCNXScienture Holdings, Inc. Press release SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion GlobeNewsWire
SCNXScienture Holdings, Inc. Press release Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline GlobeNewsWire
SCNXScienture Holdings, Inc. Press release SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041 GlobeNewsWire
SCNXScienture Holdings, Inc. Press release SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041 Globe News Wire
SCNXScienture Holdings, Inc. Stock news Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead Globe News Wire
SCNXScienture Holdings, Inc. Press release SCIENTURE Reports Year End 2025 Financial Results and Provides Business Update GlobeNewsWire
See more
FAQ

Questions about Scienture Holdings, Inc.

What does Scienture Holdings, Inc. do?
TRxADE HEALTH, Inc. operates as a health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics, and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
What is SCNX's market cap?
Scienture Holdings, Inc. (SCNX) is a listed stock with a live quote. The latest market cap on this page is $5.6M.
Where is Scienture Holdings, Inc. headquartered?
Scienture Holdings, Inc. is headquartered in Tampa, FL.
How do I get SCNX news from the API?
Call GET /v1/news?tickers=SCNX. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does SCNX news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for SCNX, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the SCNX price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs